MEGAN HOLDINGS LTD-CL A (MGN) Stock Fundamental Analysis

NASDAQ:MGN • KYG5980E1052

2 USD
+0.2 (+11.11%)
At close: Feb 27, 2026
2.01 USD
+0.01 (+0.5%)
After Hours: 2/27/2026, 8:18:40 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

MGN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 55 industry peers in the Construction & Engineering industry. MGN has only an average score on both its financial health and profitability. MGN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year MGN was profitable.
  • In the past year MGN has reported a negative cash flow from operations.
MGN Yearly Net Income VS EBIT VS OCF VS FCFMGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • MGN has a Return On Assets of 4.74%. This is comparable to the rest of the industry: MGN outperforms 60.00% of its industry peers.
  • MGN has a Return On Equity (13.13%) which is comparable to the rest of the industry.
  • MGN has a Return On Invested Capital of 13.90%. This is in the better half of the industry: MGN outperforms 76.36% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MGN is significantly above the industry average of 17.08%.
  • The last Return On Invested Capital (13.90%) for MGN is well below the 3 year average (24.57%), which needs to be investigated, but indicates that MGN had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.74%
ROE 13.13%
ROIC 13.9%
ROA(3y)12.88%
ROA(5y)N/A
ROE(3y)26.63%
ROE(5y)N/A
ROIC(3y)24.57%
ROIC(5y)N/A
MGN Yearly ROA, ROE, ROICMGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 10 20 30

1.3 Margins

  • MGN's Profit Margin of 7.94% is fine compared to the rest of the industry. MGN outperforms 78.18% of its industry peers.
  • Looking at the Operating Margin, with a value of 12.62%, MGN belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • MGN's Gross Margin of 19.70% is in line compared to the rest of the industry. MGN outperforms 58.18% of its industry peers.
Industry RankSector Rank
OM 12.62%
PM (TTM) 7.94%
GM 19.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MGN Yearly Profit, Operating, Gross MarginsMGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MGN is creating value.
  • Compared to 1 year ago, MGN has about the same amount of shares outstanding.
  • Compared to 1 year ago, MGN has an improved debt to assets ratio.
MGN Yearly Shares OutstandingMGN Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
MGN Yearly Total Debt VS Total AssetsMGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • MGN has an Altman-Z score of 2.92. This is not the best score and indicates that MGN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • MGN has a Altman-Z score of 2.92. This is comparable to the rest of the industry: MGN outperforms 49.09% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that MGN is not too dependend on debt financing.
  • MGN has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. MGN outperforms 85.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.92
ROIC/WACC1.42
WACC9.8%
MGN Yearly LT Debt VS Equity VS FCFMGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

  • MGN has a Current Ratio of 1.52. This is a normal value and indicates that MGN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of MGN (1.52) is better than 72.73% of its industry peers.
  • A Quick Ratio of 1.52 indicates that MGN should not have too much problems paying its short term obligations.
  • MGN's Quick ratio of 1.52 is fine compared to the rest of the industry. MGN outperforms 76.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
MGN Yearly Current Assets VS Current LiabilitesMGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for MGN have decreased strongly by -42.27% in the last year.
  • MGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.26%.
EPS 1Y (TTM)-42.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-29.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MGN Yearly Revenue VS EstimatesMGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 20M 40M 60M 80M

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.00, MGN can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of MGN indicates a somewhat cheap valuation: MGN is cheaper than 78.18% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.07. MGN is around the same levels.
Industry RankSector Rank
PE 25
Fwd PE N/A
MGN Price Earnings VS Forward Price EarningsMGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MGN is valued cheaper than 85.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.6
MGN Per share dataMGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MGN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MEGAN HOLDINGS LTD-CL A

NASDAQ:MGN (2/27/2026, 8:18:40 PM)

After market: 2.01 +0.01 (+0.5%)

2

+0.2 (+11.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.06%
Inst Owner Change237.85%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.50M
Revenue(TTM)60.29M
Net Income(TTM)4.78M
AnalystsN/A
Price TargetN/A
Short Float %0.42%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 25
Fwd PE N/A
P/S 2.1
P/FCF N/A
P/OCF N/A
P/B 3.47
P/tB 3.47
EV/EBITDA 10.6
EPS(TTM)0.08
EY4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.95
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.02
Profitability
Industry RankSector Rank
ROA 4.74%
ROE 13.13%
ROCE 20.64%
ROIC 13.9%
ROICexc 36.64%
ROICexgc 36.64%
OM 12.62%
PM (TTM) 7.94%
GM 19.7%
FCFM N/A
ROA(3y)12.88%
ROA(5y)N/A
ROE(3y)26.63%
ROE(5y)N/A
ROIC(3y)24.57%
ROIC(5y)N/A
ROICexc(3y)33379.7%
ROICexc(5y)N/A
ROICexgc(3y)33379.7%
ROICexgc(5y)N/A
ROCE(3y)36.5%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.04
Cap/Depr 4.49%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z 2.92
F-Score3
WACC9.8%
ROIC/WACC1.42
Cap/Depr(3y)1522310%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.86%
OCF growth 3YN/A
OCF growth 5YN/A

MEGAN HOLDINGS LTD-CL A / MGN FAQ

What is the ChartMill fundamental rating of MEGAN HOLDINGS LTD-CL A (MGN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MGN.


What is the valuation status of MEGAN HOLDINGS LTD-CL A (MGN) stock?

ChartMill assigns a valuation rating of 2 / 10 to MEGAN HOLDINGS LTD-CL A (MGN). This can be considered as Overvalued.


How profitable is MEGAN HOLDINGS LTD-CL A (MGN) stock?

MEGAN HOLDINGS LTD-CL A (MGN) has a profitability rating of 4 / 10.


Can you provide the financial health for MGN stock?

The financial health rating of MEGAN HOLDINGS LTD-CL A (MGN) is 5 / 10.